Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia

Journal of the Neurological Sciences
S NakanoM Kameyama

Abstract

Acetylcholinesterase (AChE) in the cerebrospinal fluid (CSF) from patients with Alzheimer-type dementia and control subjects was analyzed by centrifugation on a sucrose density gradient, and by column chromatography on Sephadex G-200. The sedimentation coefficient and molecular weight of CSF AChE were calculated as 10S and 380,000, respectively, which corresponded to those of G4 isozyme in the brain. Other isozymes of AChE were not detected in the CSF of either patients with Alzheimer-type dementia or the controls. Sufficient activity of AChE was observed in the CSF of a patient with familial pseudocholinesterase deficiency, although the pseudocholinesterase activity was not found either in the serum or in the CSF. CSF AChE activity in control subjects increased with advancing age (P less than 0.02). AChE activity in the CSF was significantly lower in patients with presenile dementia (Alzheimer's disease), compared with age-matched control subjects (P less than 0.001). However, AChE activity in the CSF showed a wide variation among patients of Alzheimer-type dementia with a late onset (senile dementia).

References

Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
May 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·E K PerryR H Perry
Aug 1, 1985·Journal of the Neurological Sciences·J R AtackB E Tomlinson
Dec 1, 1971·Clinica Chimica Acta; International Journal of Clinical Chemistry·S Johnson, E F Domino
Jun 25, 1983·Lancet·W Bondareff
Aug 20, 1983·Lancet·M E AppleyardM M Esiri
Mar 31, 1984·British Medical Journal·M N RossorM Roth
Jan 1, 1982·Annual Review of Neuroscience·J Massoulié, S Bon
Feb 1, 1980·Age and Ageing·E K Perry
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Mar 8, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Jyrki T Kuikka

❮ Previous
Next ❯

Citations

May 1, 1992·Neurochemical Research·N OganeE Messamore
Jan 1, 1991·Journal of Neural Transmission. General Section·J SirviöP J Riekkinen
Jan 1, 1994·European Archives of Psychiatry and Clinical Neuroscience·H J KoponenP J Riekkinen
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·P HartikainenP J Riekkinen
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J Sirviö, P J Riekkinen
Aug 15, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·R V RaoA S Balasubramanian
Nov 1, 1987·Journal of the Neurological Sciences·J SirviöP J Riekkinen
May 1, 1993·Respiration Physiology·S ItabashiH Sasaki
Dec 1, 1988·Journal of Neurochemistry·J Goemaere-VannesteP van den Bosch de Aguilar
Dec 12, 2018·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·Fatemeh Ahmadi-MotamayelMehrangiz Vahabian
Apr 1, 1988·Journal of Bioluminescence and Chemiluminescence·G MoliniF Savoldi
Oct 1, 1991·Journal of the American Geriatrics Society·W A van Gool, P A Bolhuis
Feb 1, 1988·Neurochemical Research·K J ReinikainenM Laakso
Nov 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·F J HuffJ Protetch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.